Ebola and the need for restructuring pharmaceutical incentives

The West African Ebola epidemic has created market demand for the rapid development of vaccines and therapeutics, but the current global patent system does not ensure that the poor will have access to these products.

Saved in:
Bibliographic Details
Published inJournal of global health Vol. 5; no. 1; p. 010303
Main Authors Karan, Abraar, Pogge, Thomas
Format Journal Article
LanguageEnglish
Published Scotland Edinburgh University Global Health Society 01.06.2015
Subjects
ebola
pharmaceutical incentives
Viewpoint
Online AccessGet full text

Cover

More Information
Summary:The West African Ebola epidemic has created market demand for the rapid development of vaccines and therapeutics, but the current global patent system does not ensure that the poor will have access to these products.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2047-2978
2047-2986
DOI:10.7189/jogh.05.010303